MAIA

Healthcare Biotechnology

MAIA Biotechnology, Inc.

$1.21

+0.03 +2.54% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 6, 2026, live at 11:18 AM ET	1.21

Key Stats

Market Cap

74.71M

Avg Volume

543,515

EPS

-$0.62

52W High

$3.19

52W Low

$0.87

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

1.09

P/B Ratio

3.56

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(218.7%)

Return on Assets

(92.1%)

Liquidity & Leverage

Current Ratio

4.51

Quick Ratio

4.41

Total Cash

27.60M

Total Debt

About

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

maiabiotech.com